Skip to content
Bomb Report – Lifestyle
Author:
Foghorn Therapeutics, Inc.
Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in November
November 3, 2026
Foghorn Therapeutics Provides Update on FHD-909 and Strategic Priorities
October 1, 2026
Foghorn Therapeutics Provides Second Quarter 2026 Financial and Corporate Update
August 6, 2026
Foghorn Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026
June 5, 2026
Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in May
May 12, 2026